Novo Nordisk A/S (NVO) Stock Forecast
Data as of Aug 8, 2026Healthcare · Current price $47.24 (+2.76%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
NVO vs Sector & Market
| Metric | NVO | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.25 | 2.42 |
| Analyst Count | 2 | 8 | 18 |
| Target Upside | -0.5% | +16286.4% | +14.7% |
| P/E Ratio | 11.50 | 3.58 | 36.06 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $69.62B | $71.98B | $74.11B | 2 |
| 2026-12-31 | $70.36B | $72.75B | $74.90B | 2 |
| 2027-03-31 | $75.48B | $78.04B | $80.36B | 2 |
| 2027-06-30 | $77.02B | $79.63B | $81.99B | 2 |
| 2027-09-30 | $76.29B | $78.88B | $81.21B | 2 |
| 2027-12-31 | $80.64B | $83.38B | $85.85B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $5.07 | $5.29 | $5.50 | 1 |
| 2026-12-31 | $4.59 | $4.80 | $4.98 | 1 |
| 2027-03-31 | $5.84 | $6.10 | $6.34 | 1 |
| 2027-06-30 | $5.61 | $5.86 | $6.08 | 1 |
| 2027-09-30 | $5.41 | $5.65 | $5.87 | 1 |
| 2027-12-31 | $5.01 | $5.24 | $5.44 | 1 |
Frequently Asked Questions
What is the analyst consensus for NVO?
The consensus among 2 analysts covering Novo Nordisk A/S (NVO) is Hold with an average price target of $45.00.
What is the highest price target for NVO?
The highest analyst price target for NVO is $45.00.
What is the lowest price target for NVO?
The lowest analyst price target for NVO is $45.00.
How many analysts cover NVO?
2 analysts have issued ratings for Novo Nordisk A/S in the past 12 months.
Is NVO a buy or sell right now?
Based on 2 analyst ratings, NVO has a consensus rating of Hold (3.00/5) with a -0.5% upside to the consensus target of $45.00.
What are the earnings estimates for NVO?
Analysts estimate NVO will report EPS of $5.29 for the period ending 2026-09-30, with revenue estimated at $71.98B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.